Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.41 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 7/20 | 0.34 |
| ▸ | BCHE | P06276 | 3/20 | 0.34 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.34 |
| ▸ | FAAH | O00519 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | MAOB | P27338 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27495352 | 0.73 | CYP4F2 (0.43) | CYP4F2CYP4A11 | |
| SCHEMBL8348551 | 0.70 | — | — | |
| SCHEMBL1995396 | 0.67 | CYP4F2 (0.69) | CYP4F2CYP4A11ACHE | |
| SCHEMBL1995725 | 0.66 | CYP4F2 (0.49) | CYP4F2CYP4A11RAB9AACHE | |
| SCHEMBL21810570 | 0.66 | CYP4F2 (0.47) | CYP4F2CYP4A11 | |
| SCHEMBL15763925 | 0.65 | CYP4F2 (0.47) | CYP4F2CYP4A11RAB9A | |
| SCHEMBL28903806 | 0.65 | SLC6A9 (0.35) | CYP4F2CYP4A11ACHERIPK1FAAH | |
| SCHEMBL15343541 | 0.65 | MEN1 (0.56) | RAB9AACHEBCHEFAAHMAOA | |
| SCHEMBL18697338 | 0.64 | CYP4F2 (0.46) | CYP4F2CYP4A11RAB9A | |
| SCHEMBL188333 | 0.64 | THRB (0.42) | CYP4F2CYP4A11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2271346-A2 | MONOCYCLIC CGRP RECEPTOR ANTAGONISTS | Merck Sharp & Dohme Corp. (US) | 2011-01-12 | — | — | EP | disclosed |
| WO-2009120652-A2 | MONOCYCLIC CGRP RECEPTOR ANTAGONISTS | MERCK & CO., INC. (US) | 2009-10-01 | — | — | WO | disclosed |